New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Bladder cancer: What you should know about diagnosis, treatment and recurrence

Bladder cancer: What you should know about diagnosis, treatment and recurrence

byMayo ClinicCredit: Unsplash/CC0 Public DomainBladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely
World medicine December 06,2023
Bladder cancer: What you should know about diagnosis, treatment and recurrence

Bladder cancer: What you should know about diagnosis, treatment and recurrence

byMayo ClinicCredit: Unsplash/CC0 Public DomainBladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely
World medicine December 06,2023
Targeting the Src N-Terminal regulatory element in cancer

Targeting the Src N-Terminal regulatory element in cancer

by Impact Journals LLCCanonical Src regulation involves the transition from an inactive closed state to an active open form. Credit: 2023 Mezquita et al.A new research perspective was published in&nbs
World medicine December 06,2023
Targeting the Src N-Terminal regulatory element in cancer

Targeting the Src N-Terminal regulatory element in cancer

by Impact Journals LLCCanonical Src regulation involves the transition from an inactive closed state to an active open form. Credit: 2023 Mezquita et al.A new research perspective was published in&nbs
World medicine December 06,2023
Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

byUniversity of Texas M. D. Anderson Cancer CenterPrimary analysis results from RAGNAR, the largest tumor agnostic trial of targeted tx to date, confirm efficacy of erda in heavily pretreated pt
World medicine December 06,2023
Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

byUniversity of Texas M. D. Anderson Cancer CenterPrimary analysis results from RAGNAR, the largest tumor agnostic trial of targeted tx to date, confirm efficacy of erda in heavily pretreated pt
World medicine December 06,2023
Targeting cellular respiration as a therapeutic strategy in glioblastoma

Targeting cellular respiration as a therapeutic strategy in glioblastoma

by Impact Journals LLCInhibitors of mitochondrial respiration. Credit: 2023 Shang et al.A new research perspective, titled "Targeting cellular respiration as a therapeutic strategy in glioblastom
World medicine December 06,2023
Targeting cellular respiration as a therapeutic strategy in glioblastoma

Targeting cellular respiration as a therapeutic strategy in glioblastoma

by Impact Journals LLCInhibitors of mitochondrial respiration. Credit: 2023 Shang et al.A new research perspective, titled "Targeting cellular respiration as a therapeutic strategy in glioblastom
World medicine December 06,2023
Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

byVan Andel Research InstituteGraphical Abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.04.017Van Andel Institute scientists have pinpointed how a specific gene mut
World medicine December 06,2023
Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

byVan Andel Research InstituteGraphical Abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.04.017Van Andel Institute scientists have pinpointed how a specific gene mut
World medicine December 06,2023
Targeting GITR in cancer immunotherapy

Targeting GITR in cancer immunotherapy

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published inOnc
World medicine December 06,2023
Targeting GITR in cancer immunotherapy

Targeting GITR in cancer immunotherapy

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published inOnc
World medicine December 06,2023
Extrachromosomal DNA detection in Barrett's esophagus linked to cancer development

Extrachromosomal DNA detection in Barrett's esophagus linked to cancer development

by Justin Jackson , Medical XpressStudy and analysis designs. a, Breakdown of the histological disease states among patients with Barrett’s esophagus in the Cambridge selected cross-sectional study, r
World medicine December 06,2023
Extrachromosomal DNA detection in Barrett's esophagus linked to cancer development

Extrachromosomal DNA detection in Barrett's esophagus linked to cancer development

by Justin Jackson , Medical XpressStudy and analysis designs. a, Breakdown of the histological disease states among patients with Barrett’s esophagus in the Cambridge selected cross-sectional study, r
World medicine December 06,2023
Australian study confirms that golfers have an elevated risk of skin cancer

Australian study confirms that golfers have an elevated risk of skin cancer

byUniversity of South AustraliaCredit: Pixabay/CC0 Public DomainNew research from the University of South Australia shows that golfers have a higher risk of skin cancer when compared to the gene
World medicine December 06,2023
Australian study confirms that golfers have an elevated risk of skin cancer

Australian study confirms that golfers have an elevated risk of skin cancer

byUniversity of South AustraliaCredit: Pixabay/CC0 Public DomainNew research from the University of South Australia shows that golfers have a higher risk of skin cancer when compared to the gene
World medicine December 06,2023
Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib approved for 800 prostate and breast cancer patients in England

by Tim Gunn,Cancer Research UKBreast cancer cells. Credit: NCIOlaparib (Lynparza), a targeted cancer drug, has been approved for hundreds of patients with certain breast cancers and prostate can
World medicine December 06,2023
Olaparib approved for 800 prostate and breast cancer patients in England

Olaparib approved for 800 prostate and breast cancer patients in England

by Tim Gunn,Cancer Research UKBreast cancer cells. Credit: NCIOlaparib (Lynparza), a targeted cancer drug, has been approved for hundreds of patients with certain breast cancers and prostate can
World medicine December 06,2023
Olaparib plus ceralasertib may benefit pediatric cancer patients with DNA-repair-deficient tumors

Olaparib plus ceralasertib may benefit pediatric cancer patients with DNA-repair-deficient tumors

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clin
World medicine December 06,2023
Olaparib plus ceralasertib may benefit pediatric cancer patients with DNA-repair-deficient tumors

Olaparib plus ceralasertib may benefit pediatric cancer patients with DNA-repair-deficient tumors

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clin
World medicine December 06,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com